Abstract
A mathematical model is constructed to study thrombin production in human ovarian follicular fluid. The model results show that the amount of thrombin that can be produced in ovarian follicular fluid is much lower than that in blood plasma, failing to reach the level required for fibrin formation, and thereby supporting the hypothesis that in follicular fluid thrombin functions to initiate cellular activities via intracellular signalling receptors. It is also concluded that the absence of the amplification pathway to thrombin production in follicular fluid is a major factor in restricting the amount of thrombin that can be produced. Titration of the initial concentrations of the various reactants in the model lead to predictions for the amount of tissue factor and phospholipid that is required to maintain thrombin production in the follicle, as well as to the conclusion that tissue factor pathway inhibitor has little effect on the time that thrombin generation is sustained. Numerical experiments to determine the effect of factor V, which is at a much reduced level in follicular fluid compared to plasma, and thrombomodulin, illustrate the importance for further experimental work to determine values for several parameters that have yet to be reported in the literature.
Similar content being viewed by others
References
Andersen, M.M., Króll, J., Byskov, A.G., Faber, M., 1976. Protein composition in the fluid of individual bovine follicles. J. Reprod. Fert. 48, 109–118.
Broze, G.J., 1992. The role of tissue factor pathway inhibitor in a revised coagulation cascade. Semin. Hematol. 29, 159–169.
Broze, G.J., 2003. The rediscovery and isolation of TFPI. J. Throm. Haemost. 1(8), 1671– 1675.
Bungay, S.D., Gentry, P.A., Gentry, R.D., 2003. A mathematical model of lipid-mediated thrombin generation. Math. Med. Biol. 20, 105–129.
Carmeliet, P., 2001. Clotting factors build blood vessels. Science 293, 1602–1604.
Carmeliet, P., Collen, D., 1996. Genetic analysis of the plasminogen and coagulation system in mice. Haemostasis 26(Suppl. 4), 132–153.
Carney, D.H., Redin, W., McCroskey, L., 1992. Role of high-affinity thrombin receptors in postclotting cellular effects of thrombin. Semin. Thromb. Hemost. 18, 91–103.
Cawthern, K.M., van ’t Veer, C., Lock, J.B., DiLorenzo, M.E., Branda, R.F., Mann, K.G., 1998. Blood coagulation in hemophilia A and hemophilia C. Blood 91(12), 4581–4592.
Coughlin, S.R., 2000. Thrombin signalling and protease-activated receptors. Nature 407, 258–264.
Eaton, D., Rodriguez, H., Vehar, G.A., 1986. Proteolytic processing of human factor VIII. Correlation of specific cleavages by thrombin, factor Xa, and activated protein C with activation and inactivation of factor VIII coagulant activity. Biochemistry 25, 505–512.
Gentry, P.A., 2004. Comparative aspects of blood coagulation. Vet. J. 168(3), 238–251.
Gentry, P., Plante, L., Schroeder, M., LaMarre, J., Young, J., Dodds, W., 2000. Human ovarian follicular fluid has functional systems for the generation and modulation of thrombin. Fertil. Steril. 73, 848–854.
Gentry, R., Ye, L., Nemerson, Y., 1995. Surface-mediated enzymatic reactions: Simulations of tissue factor activation of factor X on a lipid surface. Biophys. J. 69, 362–371.
Goldsack, N.R., Chambers, R.C., Dabbagh, K., Laurent, G.J., 1998. Thrombin. Int. J. Biochem. Cell Biol. 30, 641–646.
Golino, P., Ragni, M., Cimmino, G., Forte, L., 2002. Role of tissue factor pathway inhibitor in the regulation of tissue factor-dependent blood coagulation. Cardiovasc. Drug Rev. 20, 67– 80.
Gonzalès, J., Lesourd, S., Dreden, P.V., Richard, P., Lefèbvre, G., Brouzes, D.V., 1992. Protein composition of follicular fluid and oocyte cleavage occurrence in in vitro fertilization (IVF). J. Assist. Reprod. Genet. 9, 211–216.
Grand, R. J.A., Turnell, A.S., Grabham, P.W., 1996. Cellular consequences of thrombin-receptor activation. Biochem. J. 313, 353–368.
Hasan, S., Hosseini, G., Princivalle, M., Dong, J.-C., Birsan, D., Cagide, C., de Agostini, A.I., 2002. Coordinate expression of anticoagulant heparan sulfate proteoglycans and serine protease inhibitors in the rat ovary: A potent system of proteolysis control. Biol. Reprod. 66, 144–158.
Hirota, Y., Osuga, Y., Yoshino, O., Koga, K., Yano, T., Hirata, T., Nose, E., Ayabe, T., Namba, A., Tsutsumi, O., Taketani, Y., 2003. Possible roles of thrombin-induced activation of protease-activated receptor 1 in human luteinized granulosa cells. J. Clin. Endocrinol. Metab. 88, 3952–3957.
Jaspard, B., Fournier, N., Vieitez, G., Atger, V., Barbaras, R., Vieu, C., Manent, J., Chap, H., Perret, B., Collet, X., 1997. Structural and functional comparison of HDL from homologous human plasma and follicular fluid. Arterioscler. Thromb. Vasc. Biol. 17, 1605–1613.
Jehle, P.M., Fussgaenger, R.D., Angelus, N.K., Jungwirth, R.J., Saile, B., Lutz, M.P., 1999. Proinsulin stimulates growth of small intestinal crypt-like cells acting via specific receptors. Am. J. Pathol. 276, E262–E268.
Jesty, J., 1985. The kinetics of inhibition of thrombin by antithrombin in the presence of components of the hemostatic system. Blood 66, 1189–1195.
Kalafatis, M., Swords, N.A., Rand, M.D., Mann, K.G., 1994. Membrane-dependent reactions in blood coagulation: Role of the vitamin K dependent complexes. Biochim. Biophys. Acta 1227, 113–129.
Macfarlane, S.R., Seatter, M.J., Kanke, T., Hunter, G.D., Plevin, R., 2001. Proteinase-activated receptors. Pharmcol. Rev. 53, 245–282.
Mann, K.G., Brummel, K., Butenas, S., 2003. What is all that thrombin for? J. Throm. Haemost. 1, 1504–1514.
Mann, K.G., Butenas, S., Brummel, K., 2003. The dynamics of thrombin formation. Arterioscler. Thromb. Vasc. Biol. 23, 17–25.
Meijers, J. C.M., Tijburg, P. N.M., Bouma, B.N., 1987. Inhibition of human blood coagulation factor Xa by α2-macroglobulin. Biochemistry 26, 5932–5937.
Nagy, B., Pulay, T., Szarka, G., Csomor, S., 1989. The serum protein content of human follicular fluid and its correlation with the maturity of oocytes. Acta Physiol. Hung. 73(1), 71–75.
Narayanan, S., 1999. Multifunctional roles of thrombin. Ann. Clin. Lab. Sci. 29, 275–280.
Nesheim, M.E., Eid, S., Mann, K.G., 1981. Assembly of the prothrombinase complex in the absence of prothrombin. J. Biol. Chem. 256, 9874–9882.
Nesheim, M.E., Taswell, J.B., Mann, K.G., 1979. The contribution of bovine factor V and factor Va to the activity of prothrombinase. J. Biol. Chem. 254, 10952–10962.
Radhakrishnan, K., Hindmarsh, A.C., 1993. Description and use of LSODE, the Livermore solver for ordinary differential equations. Report UCRL-ID-113855, Lawrence Livermore National Laboratory, http://www.llnl.gov/CASC/download/download_home.html.
Riewald, M., Ruf, W., 2002. Orchestration of coagulation protease signaling by tissue factor. Trends Cardiovasc. Med. 12, 149–154.
Rigler, R., Pramanik, A., Jonasson, P., Kratz, G., Jansson, O.T., Nygren, P., Stahl, S., Ekberg, K., Johansson, B., Uhlen, S., Uhlen, M., Jornvall, H., Wahren, J., 1999. Specific binding of proinsulin C-peptide to human cell membranes. Proc. Natl. Acad. Sci. 96, 13318–13323.
Roach, L.E., Petrik, J.J., Plante, L., LaMarre, J., Gentry, P.A., 2002. Thrombin generation and presence of thrombin receptor in ovarian follicles. Biol. Reprod. 66, 1350–1358.
Salmassi, A., Lu, S., Hedderich, J., Oettinghaus, C., Jonat, W., Mettler, L., 2001. Interaction of interleukin-6 on human granulosa cell steroid secretion. J. Endocrinol. 170(2), 471–478.
Semotok, C.A., Johnson, W.H., LaMarre, J., Gentry, P.A., 2000. Amounts of selected coagulation factors in pre- and post-mortem follicular fluid are similar and do not correlate with molecular mass. Anim. Rep. Sci. 63, 177–185.
Shimada, H., Kasakura, S., Shiotani, M., Nakamura, K., Ikeuchi, M., Hoshino, T., Komatsu, T., Ihara, Y., Sohma, M., Maeda, Y., Matsuura, R., Nakamura, S., Hine, C., Ohkura, N., Kato, H., 2001. Hypocoagulable state of human preovulatory ovarian follicular fluid: Role of sulfated proteoglycan and tissue factor pathway inhibitor in the fluid. Biol. Reprod. 64, 1739–1745.
Steiner, J.P., Bhattacharya, P., Strickland, D.K., 1985. Thrombin-induced conformational changes of human α2-macroglobulin: Evidence for two functional domains. Biochemistry 24, 2993–3001.
Suchanek, E., Mujkic-Klaric, A., Grizelj, V., Simunic, V., Kopjar, B., 1990. Protein concentration in pre-ovulatory follicular fluid related to ovarian stimulation. Int. J. Gynecol. Obstet. 32, 53–59.
Thyzel, E., Siegling, S., Götting, C., Tinneberg, H.-R., Brinkmann, T., Kleesiek, K., 2003. Quantification of tissue factor pathway inhibitor in human seminal plasma and in human follicular fluid. Throm. Res. 109, 329–332.
Tracy, P.B., Nesheim, M.E., Mann, K.G., 1981. Coordinate binding of factor Va and factor Xa to the unstimulated platelet. J. Biol. Chem. 256, 743–751.
Turgeon, V.L., Salman, N., Houenou, L.J., 2000. Thrombin: A neuronal cell modulator. Throm. Res. 99, 417–427.
Vergnolle, N., Ferazzini, M., D’Andrea, M.R., Buddenkotte, J., Steinhoff, M., 2003. Proteinase-activated receptors: novel signals for peripheral nerves. Trends Neurosci. 26(9), 496–500.
Wielders, S.J., Beguin, S., Hemker, H.C., Lindhout, T., 2004. Factor XI-dependent reciprocal thrombin generation consolidates blood coagulation when tissue factor is not available. Arterioscler. Thromb. Vasc. Biol. 24(6), 1138–1142.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bungay, S.D., Gentry, P.A. & Gentry, R.D. Modelling Thrombin Generation in Human Ovarian Follicular Fluid. Bull. Math. Biol. 68, 2283–2302 (2006). https://doi.org/10.1007/s11538-006-9115-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11538-006-9115-7